Videos

Experts say recent CDC vaccine schedule changes may complicate clinician–family communication without altering the underlying evidence supporting pediatric vaccination.

Explore diagnostic challenges in severe pediatric skin disease, common management pitfalls, and when to escalate to systemic or biologic therapy.

Learn how to distinguish pediatric atopic dermatitis, psoriasis, and seborrheic dermatitis and recognize red flags that warrant dermatology referral.

Katie McMahon and Kathy Baylis, PhD, discuss research showing that prenatal exposure to hot, humid conditions has significant effects on child growth and health.

Mimi Lee, MD, PhD, noted that broader use of genomic testing could allow pediatric care to move beyond symptom-based diagnoses toward individualized treatment strategies.

Shilpa Patel, MD, MPH, says pediatricians can effectively lead asthma care by emphasizing education, trust, and frequent reassessment.

New research shows COVID-19 vaccination before or during pregnancy significantly lowers the risk of severe maternal illness and reduces rates of preterm birth.

According to Fleischer, epicutaneous immunotherapy represents a “marathon, not a sprint,” with potential long-term benefits when started young.

David Fleischer, MD, says phase 3 VITESSE results show the Viaskin peanut patch offers a safe, practical desensitization option for young children with peanut allergy.

Daniela Carvalho, MD, highlighted the role of pediatricians in guiding families through early hearing intervention and language development decisions.

As we continue our Countdown to 2026, take a look back at our top video interviews and packages of 2025.

Mimi C. Lee, MD, PhD, outlines why genomic sequencing remains a powerful but carefully targeted tool in pediatric medicine today, as advancements continue.

“We started out 2025 with an environment that was rife with myths and disinformation," said Robert H. Hopkins, Jr., MD, in this year-end recap of 2025 and the pediatric vaccine landscape.

Daniela Carvalho, MD, explained how the FDA-approved Nexa cochlear implant system may reduce interruptions in hearing for children while reinforcing the need for infection prevention.

Herbert Bravo, MD, and Marian Rewers, MD, PhD, explain how education and coordinated care are key to implementing early screening and treatment for type 1 diabetes.

A peer-to-peer discussion between Herbert Bravo, MD; and Marian Rewers, MD, PhD, examined immune-based treatments that preserved β-cell function and altered disease progression.

Herbert Bravo, MD, and Marian Rewers, MD, PhD, explored how C-peptide preservation reshaped both clinical management and economic considerations in type 1 diabetes.

Clinicians reviewed evidence linking delayed diagnosis of type 1 diabetes to lasting neurologic and metabolic consequences.

Experts discussed how the 3-stage model reframed type 1 diabetes as a condition that could be detected through earlier screening.

This introductory Special Report episode outlines how advances in staging and early detection are reshaping pediatric approaches to type 1 diabetes.

Jonathan Flyer, MD, discusses how the LEAD Pediatric Initiative is addressing persistently low rates of universal pediatric lipid screening.

GeneDx’s ExomeDx and GenomeDx tests, now FDA Breakthrough Designated, offer comprehensive genomic analysis to improve diagnosis of rare and serious diseases.

“Having a drug that [patients] can be confident in that will be highly effective as well as well tolerated is a great advantage," said Edward Hook, MD.

Clinicians now have the first oral alternative to injectable therapy for gonorrhea, a shift Angela Hasler, APRN, CPNP-PC says could ease treatment barriers and improve public health outcomes.

Following an updated policy from the American Academy of Child and Adolescent Psychiatry, Joshua Feder, MD, explains why providers should present DRBIs and NDBIs as options for autism care.

Researchers report that cheek swabs can capture early microscopic changes of ACM, offering a noninvasive path to earlier diagnosis and intervention.

Christine Eng, MD, discusses how earlier genome testing, multi-omic tools, rapid sequencing, and improved access can shorten diagnostic timelines and guide care.

Christine Eng, MD, discusses insurance, access, logistics, and result interpretation challenges affecting effective use of exome and genome sequencing.

New AAP guidance supports early use of exome and genome sequencing, offering higher diagnostic yield and faster results for children with developmental delay and ID.